1Harris NL,Jaffe ES,Diebold J. World Health Organization classification of neoplastic disease of the haematopoitic and lymphoid tissues:report of the clinical advisory committee meeting-Airlie house,Virginia,11,1997[J].Hematology,2000,(01):53-66.
7Choi IK,Kim BS,Lee KA. Efficacy of inatinib mesylate (STI571) in chronic neutrophilic leukemia with t (15;19):case report[J].American Journal of Hematology,2004,(04):366-369.
8Kensaku K,Kenji S,Koumei T. Chronic neutrophilic leukemia with acute myeloblastic transformation[J].Japanese Journal of Clinical Oncology,2000,(08):362-365.
8ZOtIMBOS NC, SYMEONIDIS A,KOURAKLI-SYMEONIDIS A.Chronic neut-rophilic leukemia with dysplastic features: a new variant of the myelodysplastic syndromes? [ J ]. Acta Haematol, 1989,82(3) :156 - 160.
9SWERDLOW SH, CAMPO E, HARRIS NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues [ M 1.4th ed. Lyon : IARC press,2008 : 14 - 367.
10JASON GOTLIBL, JULIA E. MAXSON, TRACY I. George, and Jeffrey W. Tyner. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment [ J ]. Blood September,2013,122 (10) : 1707 - 1711.
